ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1530

Activin a and Follistatin Alter Endothelial Cell and Rheumatoid Arthritis Synovial Fibroblast Adhesion and Interaction

Helge Scholz1, Iris Aykara1, Klaus Frommer2, Stefan Rehart3, Ulf Müller-Ladner4 and Elena Neumann1, 1Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus Liebig University Giessen, Bad Nauheim, Germany, 2Justus-Liebig-University Giessen, Campus Kerckhoff, Dept. of Rheumatology and Clinical Immunology, Bad Nauheim, Germany, 3Department of Orthopaedics and Trauma Surgery, Agaplesion Markus Hospital, Frankfurt, Frankfurt, Germany, 4Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany

Meeting: ACR Convergence 2020

Keywords: Adhesion, Adhesion molecules, Fibroblasts, Synovial, Inflammation, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Cytokines & Cell Trafficking Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Activin A and follistatin belong to an anti-inflammatory auto-regulatory cycle. Patients with rheumatoid arthritis (RA) have increased activin A levels in the synovial fluid and tissue. During inflammation, activin A is released systemically, then inducing its antagonist follistatin. This negative feedback is active in different cell types but not RA synovial fibroblasts (SF). Fibroblasts are known to interact with endothelial cells in inflamed tissues. Objective: Evaluation of the role of activin A and follistatin on RASF and endothelial cell interactions.

Methods: RA synovium was used for RASF isolation, HUVEC were commercially obtained. RASF and HUVEC were stimulated in mono- and coculture. Direct: RASF together with HUVEC; indirect: inserts with HUVEC separated by a membrane from RASF in the lower chamber. Stimuli: 15ng/ml activin A, 500ng/ml follistatin, 1ng/ml IL-1. Proteins were measured by ELISA. Proliferation was analyzed by BrdU assay. RASF were Calcein-AM stained for short-term cell adhesion assays in direct coculture. Cells were transferred to 24-well plates after 18h stimulation. After adhesion for 1h, non-adherent cells were removed by shaking 3x 5 min. Afterwards, cells were quantified. For the flow-adhesion assay, HUVEC were cultured on rat tail collagen coated capillary slides. HUVEC and RASF were stimulated for 4h with TNF, TNF+activin A or TNF+follistatin. After stimulation, 1×10^6 RASF were resuspended in 20ml medium. Two 1min videos were recorded at 18.4ml/h and 30.5ml/h using TNF-stimulated HUVEC or TNF-stimulated RASF on activin A or follistatin stimulated HUVEC.

Results: IL-1 induced activin A in RASF and HUVEC monoculture (8-fold, p< 0.01, 4-fold, p< 0.05) and direct and indirect coculture (5-fold, p< 0.05; 4-fold, p< 0.05). IL-1-induced activin A release was reduced by follistatin in HUVEC monoculture (12-fold, p< 0.01, n=5), direct and indirect coculture (10-fold, p< 0.01; 5-fold, p< 0.01) compared to IL-1 alone but not in RASF monoculture. IL-1-induced IL-6 release was reduced by activin A in HUVEC (42.6%, p< 0.05) and indirect coculture (31.8%, p< 0.05) but not in RASF monoculture and direct coculture. Follistatin did not alter IL-6 responses. IL-1 induced VEGF in RASF but not in HUVEC and was not altered by activin A. Proliferation of RASF, HUVEC or both was not altered by activin A or follistatin. Short-term adhesion showed no significant influence of activin A or follistatin (n=3). Flow adhesion assay showed reduced adherence / rolling of RASF on HUVEC stimulated with TNFα and activin A.

Conclusion: In direct and indirect coculture of HUVEC with RASF the effect on HUVEC is dominant leading to reduced IL-1-induced activin A release. However, the IL-1-induced IL-6 release in RASF or HUVECs was decreased by activin A in HUVEC monoculture and indirect coculture but not during cell-contact of both cell types. The direct interaction of RASF with HUVEC seems to prevent the reducing activin A effect on IL-6 release in HUVECs. Activin A seems to not to have an impact on short-term cell adhesion but first observations show that activin A has an influence on selectin-mediated adhesion under flow conditions.


Disclosure: H. Scholz, None; I. Aykara, None; K. Frommer, None; S. Rehart, None; U. Müller-Ladner, Biogen, 8; E. Neumann, None.

To cite this abstract in AMA style:

Scholz H, Aykara I, Frommer K, Rehart S, Müller-Ladner U, Neumann E. Activin a and Follistatin Alter Endothelial Cell and Rheumatoid Arthritis Synovial Fibroblast Adhesion and Interaction [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/activin-a-and-follistatin-alter-endothelial-cell-and-rheumatoid-arthritis-synovial-fibroblast-adhesion-and-interaction/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activin-a-and-follistatin-alter-endothelial-cell-and-rheumatoid-arthritis-synovial-fibroblast-adhesion-and-interaction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology